Discodermolide Synthesis via Cross-Coupling and Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The scarcity of natural discodermolide limits its evaluation as an anticancer agent due to its difficult extraction, and there is a need for improved synthetic methods to produce compounds that mimic its chemical and biological activity.

Innovation Solution

The synthesis of compounds of Formula I, II, III, and IV is achieved through specific reactions involving cross-coupling metal catalysts, metallating agents, and deprotection steps, allowing for the formation of compounds that mimic the activity of discodermolide, including carbon-carbon coupling and hydrolysis processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If natural extraction of discodermolide is used, then the compound can be obtained from marine sponge, but the scarcity and difficult extraction limit its availability for evaluation

Engineering Contradiction:
Improveavailability of discodermolideVSAvoidextraction difficulty
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent creates synthetic copies of discodermolide and its variants through chemical synthesis methods, allowing production of the compound without relying on scarce natural sources. This enables adequate quantity for evaluation while avoiding the extraction difficulties associated with natural isolation.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent modifies the chemical structure of discodermolide by changing parameters such as substituting functional groups (e.g., converting hydroxyl groups to other moieties) and adjusting molecular properties. This allows creation of analogs with potentially improved availability and reduced extraction difficulties while maintaining biological activity.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If synthetic methods are developed to produce discodermolide mimics, then compounds can be produced with mimicking activity, but the synthesis process becomes complex

Engineering Contradiction:
Improvebiological activity mimicryVSAvoidsynthesis process complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent divides the synthesis of discodermolide mimics into discrete, manageable steps involving separate reactions for different portions of the molecule. This segmentation allows complex molecules to be built from simpler precursors through modular transformations, reducing the overall complexity of the synthesis process.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs intermediary compounds and reagents that facilitate the transformation from simple starting materials to complex discodermolide mimics. These intermediaries act as bridges, enabling stepwise construction of the target molecules through well-defined chemical reactions.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If natural discodermolide is used for cancer treatment evaluation, then its microtubule stabilization activity can be assessed, but the limited quantity precludes complete biological profile evaluation

Engineering Contradiction:
Improvebiological activity evaluationVSAvoidamount available for study
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent produces synthetic copies of discodermolide in sufficient quantities to conduct comprehensive biological profile evaluations. These synthetic replicants maintain the essential microtubule stabilization activity while providing adequate material for complete pharmacological and toxicological studies.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent creates structural variants and analogs of discodermolide by modifying molecular parameters such as substituent groups and stereochemistry. These parameter changes allow exploration of structure-activity relationships and expansion of the available material for diverse biological evaluations.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These synthetic methods enable the production of stable compounds that effectively mimic the biological activity of discodermolide, such as microtubule stabilization, which can be used to inhibit cancer cell growth, including multidrug-resistant cells, and promote apoptosis in cancer cells.

Implementation Method 1

contacting compounds of Formula i and Formula xx in the presence of a catalytically effective amount of a cross-coupling metal catalyst. The cross-coupling metal catalyst facilitates a carbon-carbon coupling of the two compounds under mild reaction conditions.

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

contacting Formula i with a metallating agent. The metallating agent can be selected from a number of such agents useful for metal catalyzed cross-coupling, including boron, zinc, tin, lithium, or magnesium or aluminum

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Implementation Method 3

The deprotected compound of Formula I is contacted with Cl3CCONCO. This step is commonly performed in the presence of a hydrolyzing agent, preferably Al2O3.

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS7700783B2Synthesis of discodermolide and variants thereof
Publication Date: 2010.04.20 THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
  • US7700783B2 patent drawing
  • US7700783B2 patent drawing
  • US7700783B2 patent drawing

AI summary

Processes for synthesizing a compound of Formula (I) are provided by reacting a compound of Formula (i) with a compound of Formula (xx).